摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Γ-氯-4-甲氧基苯丁酮 | 40877-19-8

中文名称
Γ-氯-4-甲氧基苯丁酮
中文别名
γ-氯-4-甲氧基苯丁酮;4-氯-4'-甲氧基苯丁酮
英文名称
4-chloro-1-(4-methoxyphenyl)butan-1-one
英文别名
4-chloro-1-(4-methoxyphenyl)-1-butanone;4'-methoxy-4-chlorobutyrophenone;4-Chloro-4'-methoxybutyrophenone
Γ-氯-4-甲氧基苯丁酮化学式
CAS
40877-19-8
化学式
C11H13ClO2
mdl
——
分子量
212.676
InChiKey
NGBTWDPPZFGUAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    32-35 °C(lit.)
  • 沸点:
    159-163°C 2mm
  • 密度:
    1.1437 (rough estimate)
  • 闪点:
    159-163°C/2mm
  • 稳定性/保质期:
    常规情况下不会分解,没有危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    C
  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R34
  • WGK Germany:
    3
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    密封、阴凉、干燥保存。

SDS

SDS:d5b0b388761283b9c6c0d12a84be192a
查看
Name: 4-Chloro-4 -Methoxybutyrophenone 98% Material Safety Data Sheet
Synonym: None known
CAS: 40877-19-8
Section 1 - Chemical Product MSDS Name:4-Chloro-4 -Methoxybutyrophenone 98% Material Safety Data Sheet
Synonym:None known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
40877-19-8 4-Chloro-4'-Methoxybutyrophenone 98 255-125-5
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 40877-19-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: clear yellow
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 30.00 - 33.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H13ClO2
Molecular Weight: 212.68

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 40877-19-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Chloro-4'-Methoxybutyrophenone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 40877-19-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 40877-19-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 40877-19-8 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    通过三重态烷基氮烯的分子内还原环化光介导合成 2-(4-甲氧基苯基)-1-吡咯啉
    摘要:
    在甲醇中照射对甲氧基叠氮基苯丁酮 ( 1 ) 产生 2-(4-甲氧基苯基)-1-吡咯啉 ( 2 ) 和几种其他光产物。然而,在三(三甲基甲硅烷基)硅烷(TTMSS)存在下,2会选择性地形成。瞬态吸收和ESR光谱证实1的照射通过三线态酮(T 1K )的分子内能量转移形成三线态烷基氮烯3 1N 。DFT 计算表明3 1N从 TTMSS 中提取 H 原子,但没有从甲醇中提取,这解释了选择性。因此,三重态烷基氮烯可以通过从 TTMSS 中夺取 H 原子来进行选择性还原环化。
    DOI:
    10.1021/acs.orglett.3c01476
  • 作为产物:
    描述:
    1-(4-氯丁基)-4-甲氧基苯六氟磷酸钾nickel(II) triflate 作用下, 以 乙腈 为溶剂, 以67 %的产率得到Γ-氯-4-甲氧基苯丁酮
    参考文献:
    名称:
    功能化烷基芳烃的选择性镍电催化苄基C-H氧化
    摘要:
    在此,公开了由镍催化剂促进的官能化烷基芳烃的位点选择性配对电化学C-H氧化。原位形成的 Ni(II)-双氧物质能够在温和的条件下有效地实现氧化过程,底物范围广泛,具有优异的官能团兼容性,例如游离羧酸、醛、卤素(包括芳基碘)、酰胺和氨基酸。镍催化剂与水的结合使用为氧化一系列复杂程度不同的分子和药物衍生物提供了一种安全、绿色和经济的方法,展示了其在有机合成和制药工业中的潜在应用。反应结果和机理研究揭示了原位Ni(II)-双氧物种对于随后的 C(sp 3 )–H 键氧化的关键作用,并且短寿命的反应中间体(芳基自由基阳离子)被快速捕获双极超微电极 (BUME) 与纳米电喷雾电离质谱法的组合。
    DOI:
    10.1016/j.cclet.2023.108660
点击查看最新优质反应信息

文献信息

  • Ultrafast Iron-Catalyzed Reduction of Functionalized Ketones: Highly Enantioselective Synthesis of Halohydrines, Oxaheterocycles, and Aminoalcohols
    作者:Clemens K. Blasius、Vladislav Vasilenko、Lutz H. Gade
    DOI:10.1002/anie.201806196
    日期:2018.8.6
    A molecularly defined chiral boxmi iron alkyl complex catalyzes the hydroboration of various functionalized ketones and provides the corresponding chiral halohydrines, oxaheterocycles (oxiranes, oxetanes, tetrahydrofurans, and dioxanes) and amino alcohols with excellent enantioselectivities (up to >99 %ee) and conversion efficiencies at low catalyst loadings (as low as 0.5 mol %). Turnover frequencies
    分子定义的手性boxmi铁烷基络合物催化各种官能化酮的氢硼化,并提供相应的手性卤代醇,氧杂杂环(环氧乙烷,氧杂环丁烷,四氢呋喃和二恶烷)和氨基醇,具有出色的对映选择性(高达> 99%ee)和转化效率在低催化剂负载量(低至0.5 mol%)下。在−30°C时,周转频率大于40000 h -1突显了这种富含地球的金属催化剂的活性,该催化剂可耐受许多官能团。
  • A convenient enantioselective CBS-reduction of arylketones in flow-microreactor systems
    作者:Sonia De Angelis、Maddalena De Renzo、Claudia Carlucci、Leonardo Degennaro、Renzo Luisi
    DOI:10.1039/c6ob00336b
    日期:——

    A convenient, versatile, and green CBS-asymmetric reduction of aryl and heteroaryl ketones has been developed by using the microreactor technology.

    一种便捷、多用途且环保的CBS不对称还原芳基和杂芳基酮的方法已经通过使用微反应器技术得以开发。
  • NPY antagonists: spiroisoquinolinone derivatives
    申请人:Bristol-Myers Squibb Company
    公开号:US06348472B1
    公开(公告)日:2002-02-19
    A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of spiroisoquinolinone derivatives of Formula I. As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    一系列非肽类NPY拮抗剂已经合成,由式I的螺环异喹啉酮衍生物组成。 作为NPY诱导的进食行为的拮抗剂,预计这些化合物和已知类似物将作为有效的厌食剂,在促进减重和治疗进食障碍方面发挥作用。
  • Derivatised molecules for mass spectrometry
    申请人:OXFORD GENE TECHNOLOGY IP LIMITED
    公开号:EP1506959A2
    公开(公告)日:2005-02-16
    Compounds of formula (IIa): are provided where: X is a group capable of being cleaved from the α-carbon atom to form an ion of formula (I') C is a carbon atom bearing a single positive charge or a single negative charge; The invention further provides compounds of formula (IIb): where: X is a counter-ion to C. The compounds of formula (IIa) and (IIb) may form ions of formula (I') by either cleaving the C-X bond between X and the α-carbon atoms in the case of the compounds of formula (IIa) or dissociating X in the case of compounds of formula (IIb).
    式(IIa)的化合物如下所示: 其中: X是一个能够从α-碳原子上被切断以形成式(I')离子的基团; C是带有单一正电荷或单一负电荷的碳原子; 本发明还提供了式(IIb)的化合物: 其中: X是C的对离子。 式(IIa)和(IIb)的化合物可以通过在式(IIa)的化合物中切断X和α-碳原子之间的C-X键,或在式(IIb)的化合物中解离X,形成式(I')离子。
  • Synthesis of Pyrrolidines by a Csp <sup>3</sup> ‐Csp <sup>3</sup> /Csp <sup>3</sup> ‐ <i>N</i> Transition‐Metal‐Free Domino Reaction of Boronic Acids with γ‐Azido‐ <i>N</i> ‐Tosylhydrazones
    作者:Lucía Florentino、Lucía López、Raquel Barroso、María‐Paz Cabal、Carlos Valdés
    DOI:10.1002/anie.202010528
    日期:2021.1.18
    The reaction between γ‐azido‐N‐tosylhydrazones and boronic acids leads to the obtention of 2,2‐disubstituted pyrrolidines in a domino process that includes 1) diazoalkane formation, 2) intermolecular carboborylation of the diazocompound, and 3) intramolecular carborylation of the azide, and comprises the formation of a Csp3−Csp3 and a Csp3−N bonds on the same carbon atom. The reaction proceeds without
    γ-叠氮基-N-甲苯磺酰hydr与硼酸之间的反应导致在多米诺骨牌过程中获得2,2-二取代的吡咯烷,包括1)重氮烷的形成,2)重氮化合物的分子间碳基化和3)分子内碳基化叠氮化物,并且包括在同一碳原子上形成Csp 3 -Csp 3和Csp 3 -N键。该反应在微波活化下无需任何过渡金属催化剂即可进行,并且在两个反应伙伴中均具有广泛的作用范围。它可以同等效率应用于烷基和芳基硼酸。与N衍生自2-(2-叠氮基乙基)-环戊酮和环己酮的-甲苯磺酰hydr反应的非对映选择性很高,导致顺式稠合双环系统成为独特的非对映异构体。超过60个示例说明了该过程的范围,包括天然生物碱中存在的支架,并且基于DFT的计算支持了该机制建议。
查看更多